Experts have noticed an increasing number of individuals with asymptomatic liver disease and abnormal liver profile tests. Non-alcoholic fatty liver disease (NAFLD) can remain benign but also progress to severe conditions like cirrhosis and liver failure.
Some of the risk factors and co-morbidities of COVID-19 include the linkage of NAFLD with obesity, diabetes, and dyslipidemia-metabolic syndrome. It is estimated that as many as one of three Filipinos could have fatty liver.
But what mainly causes liver disease, and can it be prevented? How can one manage it and reduce the risk of becoming a more serious disease? When should a general practitioner refer patients with abnormal liver profiles to specialists?
This Friday, October 7, from 12nn to 2 pm, the University of the Philippines (UP), in partnership with UP Manila National Institutes of Health (UP-NIH), National Telehealth Center (NTC), and cooperation with UP Philippine General Hospital (UP-PGH), invites you to join the fight against C.O.V.I.D—current COVID-19 problems, other outbreaks, viruses, infections, and disasters.
In this episode of the “Stop C.O.V.I.D. Deaths” webinar, “FATTY LIVER: Why Should I Care?”, we will zero in on livers and how we can keep our livers healthy and save lives. Dr. Janus P. Ong, Head of the Liver Research Program at UP-NIH and Hepatologist-Gastroenterologist at the UP-PGH, will give you the latest information on the topic inside and outside the country.
Meanwhile, Dr. Elizabeth Paz-Pacheco, a consultant with the UP-PGH Division of Endocrinology, Diabetes, and Metabolism, will also share her perspectives in line with her work.
Dr. Stella Marie Jose, Deputy Director for Health Operations at UP-PGH, will deliver the synthesis and closing remarks.
Register here and catch our weekly live tweets and streams via the UP System Twitter account, TVUP’s YouTube channel, and Facebook page.
The award-winning UP “Stop COVID Deaths” Webinar Series is the Philippines’ first and only frontline-focused medical webinar series. It pioneered the discussion, dissemination, and adoption of knowledge on COVID-19 treatment and management. Follow our accounts to stay connected with your credible online community.
